Evidence map›Paper›PMID 26482379›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

Alison T Stopeck, Karim Fizazi, Jean-Jacques Body, Janet E Brown, Michael Carducci, Ingo Diel, Yasuhiro Fujiwara, Miguel Martín, Alexander Paterson, Katia Tonkin and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USA. Alison.Stopeck@stonybrookmedicine.edu.
Karim FizaziInstitut Gustave Roussy, University of Paris Sud, Villejuif, France.
Jean-Jacques BodyCentre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Janet E BrownCancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK.
Michael CarducciSidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Ingo DielCenter for Comprehensive Gynecology Clinic, Mannheim, Germany.
Yasuhiro FujiwaraNational Cancer Center Hospital, Tokyo, Japan.
Miguel MartínInstituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Alexander PatersonTom Baker Cancer Centre, Calgary, AB, Canada.
Katia TonkinCross Cancer Institute, Edmonton, AB, Canada.
Neal ShoreCarolina Urologic Research Center, Myrtle Beach, SC, USA.
Paul SieberLancaster Urology, Lancaster, PA, USA.
Frank KueppersUrology Associates, Christchurch, New Zealand.
Lawrence KarshThe Urology Center of Colorado, Denver, CO, USA.
Denise YardleySarah Cannon Research Institute, Nashville, TN, USA.
Huei WangAmgen Inc., Thousand Oaks, CA, USA.
Tapan ManiarAmgen Inc., Thousand Oaks, CA, USA.
Jorge ArellanoAmgen Inc., Thousand Oaks, CA, USA.
Ada BraunAmgen Inc., Thousand Oaks, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26482379
PMCPMC6828362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.